Learn, explore, and take control of your health with confidence.
Dive into research with our curated collection of cutting-edge medical research and peer-reviewed studies.
The Library of Medical Research
A foundation for a future medical search and reference engine
This library represents the foundation of a future medical search and reference engine.
Rather than ranking information by popularity or engagement, CardioAdvocate is designed to elevate medical knowledge based on credibility, relevance, and clinical impact — prioritizing trusted sources, landmark trials, professional society guidance, and expert consensus.
Welcome to the CardioAdvocate Cardiometabolic Library — a curated, evidence-based collection of references, guidelines, landmark trials, and CardioAdvocate articles organized by topic. Click any section to explore. This is a living resource that grows as new evidence emerges.
Last updated: February 2026
▸ Guidelines & Foundations (33 references)
- AACE/ACE Consensus Statement on Management of Dyslipidemia (2020)
- NLA Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- ATP III Report on High Blood Cholesterol
- NLA Recommendations Part 1: Executive Summary (2014)
- NLA Recommendations Part 2: Full Report (2014)
- ACC/AHA Guideline on Management of Blood Cholesterol (2018)
- ACC/AHA Guideline on Assessment of Cardiovascular Risk (2013)
- ESC/EAS Guidelines for Management of Dyslipidaemias (2019)
- ESC/EAS Focused Update on Dyslipidaemias (2025)
- CCS Dyslipidemia Guidelines (2021)
- AACE/ACE Guidelines for Management of Dyslipidemia (2017)
- ACC Expert Consensus: Role of Nonstatin Therapies (2022)
- USPSTF: Statin Use for Primary Prevention of CVD (2022)
- KDIGO Clinical Practice Guideline for Lipid Management in CKD (2013)
- Urgent need to treat ASCVD risk from earliest point in life
- Eliminating ASCVD by lowering LDL from birth
- Cumulative LDL-C exposure and risk of CV events
- Familial hypobetalipoproteinemia protects from ASCVD
- Ference BA: Low LDL-C for long duration reduces CV events
- Causal effect of ApoB lipoproteins on ASCVD
- LDL-C and lifetime risk in genome analysis
- Risk trajectories in young adults from Mendelian randomization
- Non-HDL-C Levels From Childhood to Adulthood and CV Events (JAMA 2024)
- Living Longer in Good Cardiovascular Health (Circulation)
▸ Biomarkers & Risk Assessment (57 references)
- Lipid biomarkers and risk of ASCVD — European Atherosclerosis Society
- Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
- Comprehensive lipid testing and management
- Apolipoprotein or Lipid Measurement for Cardiovascular Risk Assessment
- CardioAdvocate: What's Your ApoB?
- Low LDL-C and risk of cancer — PCSK9 trial analysis
- Very low LDL-C levels — Are they safe?
- LDL and lower is better: evidence from genetics
- Calculated vs. Direct LDL — systematic review
- Familial hypobetalipoproteinemia shows lifetime low LDL is safe
- Fasting is not routinely required for lipid testing
- LDL-C: How low can we go?
- Cumulative exposure to LDL-C and CV events
- Low LDL-C and hemorrhagic stroke
- LDL-C, Statins, and Cancer risk (no causal link)
- Lipoprotein(a) and cardiovascular risk — consensus from EAS
- Lipoprotein(a) as a risk factor — Framingham data
- OxPL on ApoB mediates Lp(a) risk
- Lp(a) testing — who and when
- Mendelian randomization shows Lp(a) causal for CHD
- PCSK9 inhibitors reduce Lp(a)
- Pelacarsen (TQJ230) — Lp(a) lowering ASO
- CardioAdvocate: Little Napoleon Complex — Lipoprotein(a)
- High Lp(a): Actionable Strategies for Risk Assessment and Mitigation
- Elevated Lp(a) and MACE Risk Regardless of ASCVD History (UK Biobank)
▸ Lipid Disorders & Phenotypes (14 references)
- Gene expression profiling in elderly FH patients
- Family Heart Foundation: PCSK9i still being denied
- EAS Consensus Statement on Familial Hypercholesterolemia (2013)
- AHA Scientific Statement on Familial Hypercholesterolemia (2015)
- FH Foundation
- FH prevalence and underdiagnosis
- CardioAdvocate: Hiding in Plain Sight — Familial Hypercholesterolemia
- FCS Foundation
- CardioAdvocate: Don't Forget Your Beans — CKD Phenotype
▸ Treatments & Therapies (63 references)
- 2021 Dietary Guidance to Improve Cardiovascular Health: AHA Scientific Statement
- Mediterranean diet and cardiovascular outcomes (PREDIMED)
- Healthy Dietary Patterns and Risk of All-Cause and Cause-Specific Mortality
- AHA Life's Essential 8
- Ultra-processed foods and cardiovascular disease
- Alcohol and heart disease: new evidence
- Coffee and cardiovascular health
- Exercise and cardiovascular risk reduction
- Egg consumption and cardiovascular risk
- Dietary cholesterol and cardiovascular risk: AHA advisory
- Coconut oil and cardiovascular risk
- Red meat and cardiovascular risk
- CardioAdvocate: EGGCELLENT, or Rotten Egg?
- CardioAdvocate: Killer Workouts — The Adult Athlete
- Safety of Aggressive Lipid Management
- High-Intensity Statin Use Among Patients with ASCVD
- PROSPER: Pravastatin in Elderly
- Statin therapy and reduced mortality across all age groups
- Statins for Primary Prevention in Older Adults
- Statin Therapy in People with HIV
- CardioAdvocate: Statin Apocalypse or Pleiotropic Nirvana
▸ Imaging & Diagnostics (17 references)
- MESA CAC Score Calculator
- AHA/ACC Statement on CAC Scoring
- CAC and long-term outcomes (MESA)
- CAC for guiding statin therapy in intermediate risk
- CAC score of zero and long-term CV risk
- Serial CAC scoring and progression
- Agatston score and CV risk stratification
- CAC in young adults (under 40)
- Statin use and CAC progression
- CAC testing: AHA/ACC appropriateness criteria
- CAC and non-cardiac surgery risk
- Society for CVD Prevention: Role of CAC
- CardioAdvocate: A Picture Is Worth a Thousand Words — CAC Scores
- CardioAdvocate: What Does My Calcium Score Mean?
▸ Cardiovascular Conditions (30 references)
- 4S Trial: Simvastatin and Coronary Heart Disease
- WOSCOPS: Pravastatin in Primary Prevention
- CARE: Pravastatin after MI
- AFCAPS/TexCAPS: Lovastatin in Primary Prevention (JAMA 1998)
- HPS: Heart Protection Study (Simvastatin)
- PROVE IT-TIMI 22: Intensive vs Moderate Statin after ACS (NEJM 2004)
- TNT: Treating to New Targets — Atorvastatin 80 vs 10 mg (NEJM 2005)
- GLAGOV: Evolocumab and Plaque Regression (JAMA 2016)
- JUPITER: Rosuvastatin in Elevated hsCRP
- IMPROVE-IT: Ezetimibe + Statin
- FOURIER: Evolocumab
- ODYSSEY Outcomes: Alirocumab
- REDUCE-IT: Icosapent Ethyl
- PROMINENT: Pemafibrate in Diabetes (NEJM 2022)
- CLEAR Outcomes: Bempedoic Acid
- CANTOS: Canakinumab
- COLCOT: Colchicine post-MI
- LoDoCo2: Colchicine chronic CAD
- BROADWAY: Obicetrapib (NEJM 2025)
- TANDEM: Obicetrapib + Ezetimibe (Lancet 2025)
- CardioAdvocate: Too Little, Too Late — HFrEF
- CardioAdvocate: The Enigma — HFpEF
- CardioAdvocate: Drinking Buddies — AFib and Its Cardiometabolic Companions
- CardioAdvocate: Brain Attack — How Recognizing Heart Disease May Save Your Brain
- CardioAdvocate: Cheating Death — The Heart Attack Survivor
▸ Metabolic & Systemic (8 references)
- Metabolic syndrome and cardiovascular risk
- CardioAdvocate: The Sweet Spot — Diabetes
▸ CardioAdvocate Resources (39 references)
- Hiding in Plain Sight — Familial Hypercholesterolemia
- Little Napoleon Complex — Lipoprotein(a)
- A Picture Is Worth a Thousand Words — CAC Scores
- The Itch That Rashes — Inflammation and CRP
- The Sweet Spot — Diabetes
- Too Much of a GOOD Thing — Dysfunctional HDL
- The Straw That Breaks the Camel's Back — LMHR
- Something Smells Fishy — Fish Oil Controversy
- EGGCELLENT, or Rotten Egg? — Eggs and Heart Disease
- Statin Apocalypse or Pleiotropic Nirvana — Statins
- Follow the Leader — Lipid Guidelines
- Barking Up the Wrong Tree — MASH and Fatty Liver
- The Day Dreamer — Obstructive Sleep Apnea
- Drinking Buddies — AFib and Cardiometabolic Companions
- Don't Forget Your Beans — CKD
- Age Is Just a Number — Aging and Heart Disease
- Under Pressure — Hypertension
- Brain Attack — Stroke
- Cheating Death — Heart Attack Survivor
- Killer Workouts — The Adult Athlete
- Too Little, Too Late — HFrEF
- The Enigma — HFpEF
- The Incidentaloma
- The Atherogenic Triad
- Wear Red for Women — Women's Cardiometabolic Health
- Precious Cargo — Pregnancy as a Cardiovascular Stress Test
- There's an App for That! — Why Risk Calculators Fail
- Bias — It's All Around Us
- The Wild, Wild West
- What's Your ApoB? — A Practical Approach to Lipid Management
- What Does My Calcium Score Mean?
- Who Needs to See a Cardiologist or Cardiometabolic Specialist?
- Rewriting the Code — Gene Editing Therapies
- A Cup of Joe Never Hurt Anyone — Coffee and Heart Health
CardioAdvocate helps people understand what matters — and how to speak up about it.
This library is curated by CardioAdvocate for educational purposes. Inclusion of a reference does not constitute endorsement. All links direct to publicly available resources. Content is reviewed and updated periodically as new evidence emerges.
Dive into real information.
-

Collection of Clinical Research
Filling the public in on the most up to date research and clinical studies, to spread information on real and current medical evidence. Learn for yourself, straight from the source.
-

What's My Biological Blueprint?
Bringing understanding to what your unique genetic profile is (aka your phenotype), to further uncover what works for you and your symptoms, not just the general masses.
-

Resourceful Reading Materials
Providing a collection of articles by guest doctors and medical specialists, unpacking medical concepts with rich information on further resources and next steps.
-

Medical Terminology Meanings
Clarifying medical terminology and phrases so you are no longer in the dark about what is happening in your body and in learning more as you dive into research.